Search Results

Filter Results

540 search results found

September 30, 2019 | MIT News Office

MIT.nano awards inaugural NCSOFT seed grants for gaming technologies
2024 MIT Digital Technology and Strategy Conference: Lightning Talk - Lighty AI

September 17, 2024 | Startup Exchange Video | Duration: 5:25

Lighty AI, Your AI Agent to Help You Navigate Your Workday
Richard Rabbat
Co-Founder & CEO, Lighty AI
2024 MIT Digital Technology and Strategy Conference: Lightning Talk - ProjectUs ai

September 17, 2024 | Startup Exchange Video | Duration: 2:39

AI to Build Emotional Intelligence Skills
Paul Bosco Jr.
Head of Product, ProjectUs.ai
2024 MIT Digital Technology and Strategy Conference: Lightning Talk - Maven AGI

September 17, 2024 | Startup Exchange Video | Duration: 6:57

AI Agents for Customer Experience Starting with Support
Sami Shalabi
Founder & CTO, Maven AGI
2024 MIT Digital Technology and Strategy Conference: Startup Lightning Talks Introduction

September 17, 2024 | Startup Exchange Video | Duration: 4:27

Moderator:
Catarina Madeira
Director, MIT Startup Exchange
September 29, 2021 | Startup Exchange

DHI-Akselos partnership capitalizes on revolutionary digital twin technology developed at MIT
August 9, 2019 | MIT News Office

Eight from MIT honored in 2019 Technology Review 35 Innovators Under 35
March 12, 2020 | MIT News Office

Covid-19 diagnostic based on MIT technology might be tested on patient samples soon
July 30, 2024 | MIT News Office

MIT spinout Arnasi begins applying LiquiGlide no-stick technology to help patients
Kytopen Corporation

Cambridge, MA

Biotechnology

Kytopen is developing platforms to accelerate the discovery and manufacturing of next-generation cell & gene therapies. The Flowfect technology offers a scalable, non-viral solution to deliver genetic payloads to cells in order to augment their functionality. The technology also enables continuous... More

Keywords:

Flowfect(R), Non-Viral, Gene Editing, CRISPR delivery, Continuous Processing, cell therapy, Genome Engineering, CAR T-cells, Engineered TCR T-cells